Sign In

Use the Qualified Clinical Data Registry (QCDR) to complete Merit-Based Incentive Payment System reporting.

Report on evidence-based quality measures and receive performance scores via the Quality Oncology Practice Initiative (QOPI®).

Oncology Practice Insider

ASCO’s Oncology Practice Insider provides the latest news, information, and educational tools to assist with the successful management of oncology practice and the delivery of high quality patient care. OPI offers updates on ASCO programs, services, and cancer-related health policy, Medicare news, and billing and coding best practices. To sign up for the biweekly Oncology Practice Insider newsletter, please complete this form.

On April 22, 2021, the Food and Drug Administration granted accelerated approval to dostarlimab-gxly (Jemperli, GlaxoSmithKline LLC) for adult patients with mismatch repair deficient (dMMR) recurrent or advanced endometrial cancer, as determined by an FDA-approved test, that has progressed on or following a prior  platinum-containing regimen. Read more. 
On April 23, 2021, the Food and Drug Administration granted accelerated approval to loncastuximab tesirine-lpyl (Zynlonta, ADC Therapeutics SA), a CD19-directed antibody and alkylating agent conjugate, for adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, DLBCL arising from low grade lymphoma, and high-grade B-cell lymphoma.
On May 5, 2021, the Food and Drug Administration granted accelerated approval to pembrolizumab (Keytruda, Merck & Co.) in combination with trastuzumab, fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of patients with locally advanced unresectable or metastatic HER2 positive gastric or gastroesophageal junction (GEJ) adenocarcinoma. Read more. 
In 2021, office and outpatient E&M Services are selected based on either time or medical decision making. As a reminder, to choose the appropriate CPT code based on medical decision making, two of three elements of medical decision must be met or exceeded:
ASCO’s Quality Training Program (QTP) is currently accepting applications for the summer 2021 course. Session dates are provided below. We are still determining whether the sessions will be held in person or online.
On Thursday, May 20 from 4:00 PM–5:00 PM (ET), the call will revolve around two related subjects: ASCO’s vision for equity, diversity, and inclusion, and our 2020 Sexual Orientation and Gender Identity (SOGI) survey to research health disparities among sexual and gender minority populations. Our presenters will be Sybil Green, JD, RPh, MHA, and Charles Kamen, PhD, MPH. Register to join us on May 20.
PracticeNET is pleased to announce several new developments. PracticeNET Advanced, now the core of PracticeNET reporting, has surpassed one million patient records one year after its post-pilot rollout. PracticeNET also successfully held their first all-virtual spring meeting in March, which saw record-breaking attendance with roughly fifty percent more attendees than previous meetings.
As COVID-19 vaccines continue rolling out across the country, the Centers for Medicare and Medicaid (CMS) is taking action to protect the health and safety of patients and providers and providing updates on the latest COVID-19 resources from the Department of Health and Human Services (HHS), the Centers for Disease Control and Preventions (CDC), and CMS.